TherapeuticsMD (TXMD) Profit After Tax (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Profit After Tax came in at $95000.0 in Q1 2026, up 114.55% YoY from $44279.1 in Q1 2025, and up 117.99% on a QoQ basis from -$528000.0 in Q4 2025.
TherapeuticsMD (TXMD) Profit After Tax (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Profit After Tax data on file, last reported at $95000.0 in Q1 2026.
- Quarterly Profit After Tax rose 114.55% year-over-year to $95000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168000.0 (up 107.67% YoY) and the FY2025 annual result came in at -$569000.0, up 75.39% from the prior year.
- Profit After Tax climbed to $95000.0 in Q1 2026, from -$528000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $159.4 million in Q4 2022 to a low of -$49.0 million in Q1 2022.
- A 5-year average of $11.5 million and a median of -$653000.0 in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax jumped 470.99% — and 2025, when it sank 536.36%.
- Tracing TXMD's Profit After Tax over 5 years: stood at $159.4 million in 2022, then sank by 100.55% to -$883000.0 in 2023, then surged by 113.7% to $121000.0 in 2024, then slumped by 536.36% to -$528000.0 in 2025, then surged by 117.99% to $95000.0 in 2026.
- The last three Profit After Tax figures came in at $95000.0 (Q1 2026), -$528000.0 (Q4 2025), and $50000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 164,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 164,000.00 |
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | -528,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 551,000.00 |
| Mar 31, 2025 | -653,000.00 |
| Dec 31, 2024 | 121,000.00 |
| Sep 30, 2024 | -567,000.00 |
| Jun 30, 2024 | -1.09 Mn |
| Mar 31, 2024 | -734,000.00 |
| Dec 31, 2023 | -883,000.00 |
| Sep 30, 2023 | -3.38 Mn |
| Jun 30, 2023 | -2.41 Mn |
| Mar 31, 2023 | -3.60 Mn |
| Dec 31, 2022 | 159.38 Mn |
| Sep 30, 2022 | -14.63 Mn |
| Jun 30, 2022 | 112.28 Mn |
| Mar 31, 2022 | -49.02 Mn |
| Dec 31, 2021 | -42.96 Mn |
| Sep 30, 2021 | -47.42 Mn |